A comparison of fetal abdominal circumference measurements and Doppler ultrasound in the prediction of small-for-dates babies and fetal compromise

Fetal Growth Restriction in Hypertensive vs. Heavy Smoking Women-Placental Pathology, Ultrasound Findings, and Pregnancy Outcomes

We compared placental pathology, ultrasonographic findings, and obstetric outcomes, in gestations complicated by fetal growth restriction (FGR) with either a background of hypertensive disorder or heavy tobacco cigarette smoking. The medical records and placental pathology reports of pregnancies complicated with FGR (birthweight < 10th percentile) between December 2008 and May 2018 from a single tertiary center were reviewed. Placental pathology, ultrasound findings, and pregnancy outcomes were compared between hypertensive patients (HTN) and heavy smokers (SMO). We included 213 pregnancies: 129 (60.6%) in the SMO group and 84 (39.4%) in the HTN group. The HTN group was characterized by a higher BMI (p = 0.01), higher rates of Cesarean deliveries (p = 0.006), and a lower gestational age at delivery (35.6 ± 3.8 vs. 37.5 ± 2.9 weeks, p < 0.001). The HTN group had higher rates of placental weights < 10th percentile (p = 0.04) and maternal vascular malperfusion lesions (p < 0.001), while the SMO group had higher rates of inflammatory lesions (p = 0.04). On ultrasound, the HTN group had a higher head/abdomen circumference ratio (p < 0.001) and more abnormal Doppler studies (< 0.001). Neonates in the HTN group had lower birthweights (p < 0.001) and higher rates of NICU admissions (p = 0.002) and adverse neonatal outcome (p = 0.006). On multivariable analysis, gestational age at delivery (aOR = 0.65, 95%CI 0.55-0.87), hypertensive disorders (aOR = 1.8, 95%CI = 1.21-4.81), placental MVM lesions (aOR = 1.23, 95%CI = 1.08-5.02), and the combination of HTN+MVM (aOR = 2.63, 95%CI 1.78-7.30) were independently associated with adverse neonatal outcome. Hypertension and smoking may lead to FGR in different pathways as the two groups significantly differed in maternal characteristics, placental pathology, ultrasound findings, and neonatal outcomes. A hypertensive disorder probably represents a more hostile maternal environment than smoking and these pregnancies would probably benefit from closes monitoring.

Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants

BACKGROUND

Stillbirth affects 2.6 million pregnancies worldwide each year. Whilst the majority of cases occur in low- and middle-income countries, stillbirth remains an important clinical issue for high-income countries (HICs) - with both the UK and the USA reporting rates above the mean for HICs. In HICs, the most frequently reported association with stillbirth is placental dysfunction. Placental dysfunction may be evident clinically as fetal growth restriction (FGR) and small-for-dates infants. It can be caused by placental abruption or hypertensive disorders of pregnancy and many other disorders and factorsPlacental abnormalities are noted in 11% to 65% of stillbirths. Identification of FGA is difficult in utero. Small-for-gestational age (SGA), as assessed after birth, is the most commonly used surrogate measure for this outcome. The degree of SGA is associated with the likelihood of FGR; 30% of infants with a birthweight < 10th centile are thought to be FGR, while 70% of infants with a birthweight < 3rd centile are thought to be FGR. Critically, SGA is the most significant antenatal risk factor for a stillborn infant. Correct identification of SGA infants is associated with a reduction in the perinatal mortality rate. However, currently used tests, such as measurement of symphysis-fundal height, have a low reported sensitivity and specificity for the identification of SGA infants.

OBJECTIVES

The primary objective was to assess and compare the diagnostic accuracy of ultrasound assessment of fetal growth by estimated fetal weight (EFW) and placental biomarkers alone and in any combination used after 24 weeks of pregnancy in the identification of placental dysfunction as evidenced by either stillbirth, or birth of a SGA infant. Secondary objectives were to investigate the effect of clinical and methodological factors on test performance.

SEARCH METHODS

We developed full search strategies with no language or date restrictions. The following sources were searched: MEDLINE, MEDLINE In Process and Embase via Ovid, Cochrane (Wiley) CENTRAL, Science Citation Index (Web of Science), CINAHL (EBSCO) with search strategies adapted for each database as required; ISRCTN Registry, UK Clinical Trials Gateway, WHO International Clinical Trials Portal and ClinicalTrials.gov for ongoing studies; specialist abstract and conference proceeding resources (British Library's ZETOC and Web of Science Conference Proceedings Citation Index). Search last conducted in Ocober 2016.

SELECTION CRITERIA

We included studies of pregnant women of any age with a gestation of at least 24 weeks if relevant outcomes of pregnancy (live birth/stillbirth; SGA infant) were assessed. Studies were included irrespective of whether pregnant women were deemed to be low or high risk for complications or were of mixed populations (low and high risk). Pregnancies complicated by fetal abnormalities and multi-fetal pregnancies were excluded as they have a higher risk of stillbirth from non-placental causes. With regard to biochemical tests, we included assays performed using any technique and at any threshold used to determine test positivity.

DATA COLLECTION AND ANALYSIS

We extracted the numbers of true positive, false positive, false negative, and true negative test results from each study. We assessed risk of bias and applicability using the QUADAS-2 tool. Meta-analyses were performed using the hierarchical summary ROC model to estimate and compare test accuracy.

MAIN RESULTS

We included 91 studies that evaluated seven tests - blood tests for human placental lactogen (hPL), oestriol, placental growth factor (PlGF) and uric acid, ultrasound EFW and placental grading and urinary oestriol - in a total of 175,426 pregnant women, in which 15,471 pregnancies ended in the birth of a small baby and 740 pregnancies which ended in stillbirth. The quality of included studies was variable with most domains at low risk of bias although 59% of studies were deemed to be of unclear risk of bias for the reference standard domain. Fifty-three per cent of studies were of high concern for applicability due to inclusion of only high- or low-risk women.Using all available data for SGA (86 studies; 159,490 pregnancies involving 15,471 SGA infants), there was evidence of a difference in accuracy (P < 0.0001) between the seven tests for detecting pregnancies that are SGA at birth. Ultrasound EFW was the most accurate test for detecting SGA at birth with a diagnostic odds ratio (DOR) of 21.3 (95% CI 13.1 to 34.6); hPL was the most accurate biochemical test with a DOR of 4.78 (95% CI 3.21 to 7.13). In a hypothetical cohort of 1000 pregnant women, at the median specificity of 0.88 and median prevalence of 19%, EFW, hPL, oestriol, urinary oestriol, uric acid, PlGF and placental grading will miss 50 (95% CI 32 to 68), 116 (97 to 133), 124 (108 to 137), 127 (95 to 152), 139 (118 to 154), 144 (118 to 161), and 144 (122 to 161) SGA infants, respectively. For the detection of pregnancies ending in stillbirth (21 studies; 100,687 pregnancies involving 740 stillbirths), in an indirect comparison of the four biochemical tests, PlGF was the most accurate test with a DOR of 49.2 (95% CI 12.7 to 191). In a hypothetical cohort of 1000 pregnant women, at the median specificity of 0.78 and median prevalence of 1.7%, PlGF, hPL, urinary oestriol and uric acid will miss 2 (95% CI 0 to 4), 4 (2 to 8), 6 (6 to 7) and 8 (3 to 13) stillbirths, respectively. No studies assessed the accuracy of ultrasound EFW for detection of pregnancy ending in stillbirth.

AUTHORS' CONCLUSIONS

Biochemical markers of placental dysfunction used alone have insufficient accuracy to identify pregnancies ending in SGA or stillbirth. Studies combining U and placental biomarkers are needed to determine whether this approach improves diagnostic accuracy over the use of ultrasound estimation of fetal size or biochemical markers of placental dysfunction used alone. Many of the studies included in this review were carried out between 1974 and 2016. Studies of placental substances were mostly carried out before 1991 and after 2013; earlier studies may not reflect developments in test technology.

Accurate and fast feature selection workflow for high-dimensional omics data

We are moving into the age of ‘Big Data’ in biomedical research and bioinformatics. This trend could be encapsulated in this simple formula: D = S * F, where the volume of data generated (D) increases in both dimensions: the number of samples (S) and the number of sample features (F). Frequently, a typical omics classification includes redundant and irrelevant features (e.g. genes or proteins) that can result in long computation times; decrease of the model performance and the selection of suboptimal features (genes and proteins) after the classification/regression step. Multiple algorithms and reviews has been published to describe all the existing methods for feature selection, their strengths and weakness. However, the selection of the correct FS algorithm and strategy constitutes an enormous challenge. Despite the number and diversity of algorithms available, the proper choice of an approach for facing a specific problem often falls in a ‘grey zone’. In this study, we select a subset of FS methods to develop an efficient workflow and an R package for bioinformatics machine learning problems. We cover relevant issues concerning FS, ranging from domain’s problems to algorithm solutions and computational tools. Finally, we use seven different proteomics and gene expression datasets to evaluate the workflow and guide the FS process.

Defining fetal growth restriction: abdominal circumference as an alternative criterion

PURPOSE

The purpose of this study is to determine if using abdominal circumference percentile (AC) to define fetal growth restriction (FGR) improves ultrasound at ≥36 weeks as a screening test for small for gestational age (SGA).

MATERIALS AND METHODS

All non-anomalous singletons undergoing ultrasound at a single center at ≥36 weeks during 12/2008-5/2014 were included. FGR was defined as (estimated fetal weight) estimated fetal weight (EFW) and/or abdominal circumference (AC) < 10 for gestational age (GA). The primary outcome was SGA (birthweight ≤10th percentile for GA). Data were stratified by maternal race/ethnicity and BMI. Sensitivity, specificity, false-positive rate (FPR), positive- and negative-predictive values (positive-predictive value (PPV), negative-predictive value (NPV)), and areas under the receiver-operating characteristic (ROC) curve (AUC were calculated.

RESULTS

There were 1594 ultrasounds. Median (IQR) ultrasound GA was 37.3 (36.6-38.0), days to delivery 10.6 (5.0-18.4), and delivery GA 39.29 (38.6-39.9). EFW <10 had the following characteristics: sensitivity 50.6%, FPR 2.0%, PPV 83.8%, and AUC 0.743. Using AC <10, these were 64.0, 2.9, 81.3, and 0.806, respectively. Using AC or EFW <10, these were 67.5, 3.3, 80.3, and 0.821, respectively; this criterion has the largest AUC (p < .008). This finding persisted when stratified by maternal race/ethnicity and BMI.

CONCLUSIONS

AC <10 is more sensitive and has a similar PPV compared with EFW <10 for SGA. Using AC <10 or EFW <10 has the best balance of sensitivity and specificity as a screening test and has a low FPR. AC may be a reasonable alternative criterion to EFW for FGR diagnosis.

Predictive values of maternal serum PAPP-A level, uterine artery Doppler velocimetry, and fetal biometric measurements for poor pregnancy and poor neonatal outcomes in pregnant women

OBJECTIVE

To determine predictive values of maternal serum PAPP-A (msPAPP-A) levels, uterine artery Doppler velocimetry, and fetal biometric measurements (FBMs) for poor pregnancy and poor neonatal outcomes.

MATERIAL AND METHODS

This prospective cohort study was conducted on singleton pregnancies followed until delivery. Pregnancy and neonatal outcomes were evaluated with respect to the msPAPP-A level at the 11(th)-14(th) weeks, uterine artery Doppler velocimetry at the 15(th)-18(th) weeks, and FBMs at the 20(th)-24(th) and 28(th)-32(nd) weeks of pregnancy.

RESULTS

One hundred fifty-eight women constituted the study group; 17 (10.75%) of them had at least one poor pregnancy outcome. The cut-off point of 0.72 multiple of the median (MoM) for the PAPP-A level achieved a sensitivity of 82.4% and a specificity of 29.8% for poor pregnancy outcomes. The mean birth weight was significantly lower in the subgroup with a higher mean pulsatility index of uterine arteries (UAPImean≥1.19) (p=0.025) as well as in the subgroup with a higher mean resistance index of uterine arteries (UARImean≥0.62) (p=0.013). When the subgroup of pregnant women under the risk of early-onset IUGR according to FBMs was compared to the low-risk group, statistically significant differences were seen in terms of pregnancy outcomes (p=0.045) and birth weight (p=0.011).

CONCLUSION

Maternal serum PAPP-A level and FBMs could be used for predicting pregnancy outcomes, while uterine artery Doppler velocimetry and FBMs could be used for predicting neonatal outcomes, specifically the birth weight.

Hepato - Cephalic Index as a Predictor of Intrauterine Growth Restriction

Aim:

The aims of this study were to compare ultrasound fetoplacental parameters and to calculate Hepato-Cephalic Index (HCI) as a new predictor of IUGR.

Methods and material:

A clinical prospective study was conducted and included 120 pregnant women divided in two groups: non IUGR group included healthy pregnant women (n=60) and IUGR group included pregnant women with preeclampsia and IUGR (n=60). Outcome measures were following ultrasound fetoplacental parameters in fetuses with IUGR and non IUGR: Fetal Liver Length (FLL), Femur Length (FL), Biparietal Diameter (BPD), Placental Maturation by Grannum, Amniotic Fluid Index (AFI) and Hepato-Cephalic Index (HCI). Sonography was carried out by probe 3.5 Mhz type MINDRAY DC 7.

Results:

The mean of maternal age was 30.0±6.1 years in women with preeclampsia and IUGR and 28.1±5.1 years in healthy pregnant women, p > 0.05. There was a statistically significant difference in values of: FLL (p < 0.001), FL (p = 0.004), BPD (p < 0.001), AFI (p < 0.001), HCI (p < 0.001) between IUGR and non IUGR groups. The most of women with preeclampsia and IUGR had grade III of placental maturation (48.3%). There is a significant association between the placental maturation and the diagnosis, p < 0.001. There was a statistically significant difference in body mass of newborns between IUGR and non IUGR groups, p < 0.001.

Conclusion:

In a fetus with IUGR in preeclampsia there is a reduction in FLL, FL, BPD, AFI and HCI and there is a early maturation of the placenta. By measurement of fetoplacental ultrasonic parameters of liver, pregnant women will experience prediction of risk pregnancy (preeclampsia with IUGR) due to hypoxia.

Umbilical artery Doppler in the assessment of fetal growth restriction

Antepartum fetal surveillance with Doppler ultrasound of umbilical artery has shown significant diagnostic efficacy in identifying fetal compromise in pregnancies complicated with fetal growth restriction (FGR). Its effectiveness in decreasing perinatal mortality has been shown by randomized clinical trials (Level I evidence). This test is the only antepartum fetal test that has shown this level of effectiveness and should be the standard of practice in managing FGR (Level A recommendation). The overall management considerations should encompass other standard fetal monitoring tests (Level B and C recommendations).

Doppler ultrasonography in uteroplacental insufficiency

Much of our understanding of uteroplacental insufficiency has been derived from animal research and the study of the pathology of human placental and uterine biopsies. These studies have shown how the placenta plays a major role in the development of normal pregnancy and how placental dysfunction is generally caused by factors interfering with the normal growth of the uteroplacental and/or fetoplacental circulations. These abnormalities lead to a deficient supply of oxygen and nutrients to the fetus and to several complications of pregnancy such as gestational hypertension, preeclampsia and intrauterine growth retardation (IUGR).

Abdominal circumference: a single measurement versus growth rate in the prediction of intrapartum Cesarean section for fetal distress

OBJECTIVE

The fetal abdominal circumference is the most sensitive ultrasound biometric measurement for predicting intrauterine growth restriction, which is associated with an increased risk of intrapartum fetal distress. We sought to evaluate and compare whether a third-trimester ultrasound measurement of abdominal circumference made within 1 week prior to delivery better predicts operative delivery for fetal distress when compared with the growth velocity of the abdominal circumference in the third trimester.

METHODS

Retrospective analysis was carried out of prospectively collected ultrasound data on 117 patients with singleton gestations who had had at least two ultrasound assessments performed less than 6 weeks apart in the third trimester, with the last ultrasound performed within 1 week prior to delivery. The abdominal circumference value of the last ultrasound prior to delivery was placed into one of three categories: < or = 5% centile, > 5 to < or = 10% centile and > 10% centile for gestational age. The growth velocity of the abdominal circumference per week was placed into one of three categories: < or = 5 mm/week, 6-10 mm/week and > or = 11 mm/week. The chi-squared test was used to compare differences between the incidence of fetal distress between the groups.

RESULTS

The incidences of Cesarean section for fetal distress in relation to a single measurement of the abdominal circumference were: < or = 5% centile, 8/23 (35%); > 5 to < or = 10% centile, 3/12 (25%); > 10% centile, 8/81 (10%) ( P < 0.05). The incidences of Cesarean section for fetal distress with the three abdominal circumference growth velocities were: < or = 5 mm/week, 9/55 (16%); 6-10 mm/week, 4/11 (36%); > or = 11 mm/week, 8/51 (16%) ( P = 0.9401).

CONCLUSION

A single measure of the fetal abdominal circumference made within 1 week prior to delivery is superior to an assessment of growth rate of the fetal abdomen in the third trimester in discriminating patients who require Cesarean section for fetal distress.

Sonographic diagnosis of intrauterine growth restriction (IUGR) by fetal transverse cerebellar diameter (TCD)/abdominal circumference (AC) ratio

OBJECTIVE

To evaluate the validity of TCD/AC ratio in predicting IUGR.

STUDY DESIGN

Prospective descriptive analysis.

SETTING

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University.

SUBJECTS

Women meeting the inclusion criteria consisting of: (1) singleton pregnancies after 28 weeks of gestation; (2) known accurate gestational age; and (3) clinically suspected IUGR.

METHODS

The patients were sonographically examined for TCD/AC ratio. The best cut-off value of TCD/AC ratio in predicting IUGR was determined by a receiver operating characteristic (ROC) curve. The fetus with a TCD/AC ratio greater than the cut-off value would be antenatally diagnosed as IUGR for every gestational week. Standard definition of IUGR was a low birthweight, less than the 10th percentile.

RESULTS

One hundred and sixty-seven pregnancies with suspected IUGR were analyzed. The prevalence of IUGR among the study group was 51.5%. The best cut-off value of the TCD/AC ratio for predicting IUGR was 15.4%, giving the sensitivity, specificity, positive predictive value and negative predictive value of 73.26%, 80.25%, 79.75%, and 73.86%, respectively.

CONCLUSION

The sonographic fetal TCD/AC ratio as a gestational age-independent method can be helpful in antenatal diagnosis of IUGR, especially in pregnancy with uncertain gestational age.

The fetal outcome in pregnancies with isolated reduced amniotic fluid volume in the third trimester

Our aim was to assess the outcome of pregnancies where oligohydramnios, defined by a published gestational reference range for amniotic fluid index, was the only abnormal finding at third trimester scan, and all other ultrasound parameters including biometry were within normal limits at initial scan. A retrospective case-control study was performed at The Liverpool Maternity Hospital. 103 pregnancies with reduced amniotic fluid index in the third trimester and apparently normal fetal growth profile ultrasonographically were identified from ultrasound reports throughout 1993. Pregnancies in the third trimester with normal amniotic fluid index on index scan were also identified from these reports and 103 were matched for parity, gestational age at delivery, mode of onset of labour, presentation at labour and medical conditions. Exclusion criteria were ruptured membranes, fetal abnormalities, estimated fetal weight below the fifth centile at index scan and multiple pregnancies. The outcome criteria were birthweight, Apgar scores at delivery, induction and emergency delivery for fetal reasons and admission to Neonatal Intensive Care Unit. Statistical analysis was performed by Fisher's exact test and Gart's odds ratio. Compared with controls, pregnancies in the reduced liquor group had a higher number of babies below the 5th centile (odds ratio 5.2, 95% confidence interval 1.6 to 22), a higher risk of induction for fetal reasons (odds ratio 34.4, 95% confidence interval 5.35 to 1425.5) and admission to Neonatal Intensive Care Unit (odds ratio 9.77, 95% confidence interval 1.3 to 432). Any observed difference in the need for emergency delivery due to fetal reasons was not clinically significant (odds ratio 2.16, 95% confidence interval 0.77 to 6.6) The definition used for oligohydramnios used in this study appears to identify a group of babies with a fourfold risk of low birthweight and a high risk of admission to the Neonatal Intensive Care Unit and induction of labour for fetal reasons. This would suggest that pregnancies with isolated oligohydramnios require some form of fetal monitoring and further prospective studies are required to determine the most appropriate method.

Standards for the quantification of serial changes in Doppler resistance indices from the umbilical arteries

Two-hundred- and-seventy-four low-risk pregnancies underwent serial ultrasound examinations in order to determine the mean and standard deviation of the change in umbilical artery resistance indices with advancing gestation. There is an almost constant rate of reduction in the A/B ratio and the Pulsatility index over time from 28 weeks gestation until term. By calculating the standard deviation score of such changes, these reference ranges allow the change in the A/B ratio and Pulsatility index to be quantified. Such appropriately derived standards permits the further investigation of the evolution of abnormalities of feto-placental perfusion with regards to perinatal outcome.

Fetal size and growth velocity in the prediction of intrapartum caesarean section for fetal distress

OBJECTIVE

To evaluate and compare third trimester ultrasound measurements of fetal size and growth velocity in the prediction of intrapartum operative delivery for fetal distress and admission to the special care baby unit in a low risk antenatal population undergoing labour at term.

DESIGN

Retrospective analysis of prospectively collected ultrasound data.

SETTING

Ninewells Hospital, Dundee, Scotland.

POPULATION

Three hundred and ninety-eight women previously enrolled in a longitudinal study of intrauterine volume undergoing labour at a gestational age of > 37 weeks.

METHOD

Fetal abdominal area (FAA) standard deviation scores (Z scores) were calculated for size at 32 and 36 weeks of gestation together with the growth velocity Z scores between these two gestational ages. Receiver-operator characteristics were calculated for fetal abdominal area Z scores at 32, 36 weeks and velocity Z scores in the prediction of caesarean section for fetal distress and/or admission to the special care baby unit.

MAIN OUTCOME MEASURES

Intrapartum caesarean section for fetal distress and admission to the special care baby unit with a diagnosis of perinatal hypoxia.

RESULTS

Pregnancies ending in caesarean section for fetal distress or admission to the special care baby unit (n = 17) had significantly lower fetal abdominal area Z scores at 36 weeks of gestation (mean Z score -0.71 vs -0.18) and lower fetal abdominal area growth velocity (mean Z score - 1.31 vs -0.01). Taking a cutoff Z score of -1.2 derived from the receiver-operator characteristic curve, fetal abdominal area velocity has a sensitivity of 65% and specificity 75% for caesarean section for fetal distress and/or admission to the special care baby unit.

CONCLUSION

Growth velocity of the fetal abdominal area in the third trimester is superior to a single measurement of the fetal abdominal area at either a mean of 32 or 36 weeks of gestation in the prediction of caesarean section for fetal distress and admission to the special care baby unit in low-risk women labouring at term. These results support the hypothesis that in the third trimester at least, growth rate in utero is more relevant to intrapartum performance and immediate perinatal outcome than estimates of fetal size alone.

Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound

OBJECTIVE

To compare fetal growth assessed by ultrasound (change in standard deviation score of abdominal circumference and estimated fetal weight) during the third trimester with predelivery ultrasound measurements of fetal size and Doppler measurements from the umbilical and fetal arteries in order to predict suboptimal perinatal outcome in small babies at term.

DESIGN

Prospective observational study.

SETTING

Day assessment unit in a university hospital.

SUBJECTS

One hundred and four consecutive women with a clinical suspicion of a small fetus during the third trimester confirmed by ultrasound (abdominal circumference below the 10th centile) and ultimately delivered at term.

MAIN OUTCOME MEASURES

Acidaemia at birth, fetal distress requiring emergency caesarean section in labour, admission to the neonatal intensive care unit.

RESULTS

Ninety-four babies (90%) weighed less than the 10th centile and the incidence of suboptimal perinatal outcome was 27%. The largest areas under the receiver operating characteristic curves for suboptimal perinatal outcome were obtained with the change in standard deviation score of abdominal circumference and estimated fetal weight, and the ratios of aortic/middle cerebral and renal/middle cerebral pulsatility index. Although low, the odds ratios of the change in estimated fetal weight standard deviation score and the Doppler ratios were significantly different from zero.

CONCLUSION

Ultrasound assessment of fetal growth and predelivery fetal Doppler pulsatility index ratios were superior to predelivery estimates of fetal size and umbilical artery pulsatility index in predicting suboptimal perinatal outcome in small fetuses delivering at term, although the clinical value of such a prediction may be limited.

Recent advances in the use of Doppler waveform indices in the antenatal assessment of intrauterine growth retardation

Doppler ultrasound has been advocated as a useful tool to evaluate pregnancies with intrauterine growth retardation (IUGR). However, many previous studies have used smallness for gestational age (SGA) at birth to define IUGR. The ability of Doppler ultrasound to predict SGA, neonatal morphometric indices of wasting such as a low ponderal index, and perinatal morbidity is reviewed. Doppler assessment of the umbilical and uteroplacental vasculatures were inferior to ultrasound measurements of fetal size in the prediction of SGA. In low risk fetuses, umbilical artery waveform indices were of limited value in the prediction of neonatal morphometric indices of wasting. Within a group of high risk fetuses, Doppler assessment of the umbilical artery and, in particular, the middle cerebral and aortic vessels, were useful in predicting fetuses with neonatal wasting. Similar findings were noted in the prediction of perinatal morbidity. The review confirms the usefulness of umbilical artery Doppler waveform indices in the antenatal assessment of IUGR. Whilst preliminary studies appear to suggest that Doppler waveform indices of the middle cerebral and aortic vessels may confer an additional advantage in the antenatal assessment of IUGR, randomized controlled trials evaluating their effect on perinatal outcome and studies on the reproducibility of these indices need to be carried out before their widespread introduction into obstetric practice.

Screening for fetal distress in labour using the umbilical artery blood velocity waveform

OBJECTIVE

To investigate the potential value of umbilical artery blood velocity wave-form measurement as a screening test for intrapartum fetal distress on admission to the labour ward.

DESIGN

Prospective study drawn from the local population of pregnant women.

SETTING

The labour ward of the Princess Anne Hospital, Southampton, UK.

SUBJECTS

334 women with singleton pregnancies of at least 37 weeks gestation.

MAIN OUTCOME MEASURE

Emergency caesarean section for fetal distress.

RESULTS

There was a twelve-fold increase in the rate of emergency caesarean section for fetal distress (95% Confidence Interval (CI), 4.9-29) among women with a systolic/diastolic (S/D) ratio > or = 3.0, when compared to those with an S/D ratio of < 3.0 (P < 0.00001). Measurement of the umbilical artery blood velocity waveform compared favourably with admission cardiotocography.

CONCLUSIONS

Umbilical artery blood velocity waveform analysis may be used to screen for fetal distress in labour and appears to be particularly sensitive to problems of placental origin. However, it is not likely to confer benefit in labour wards whose fetal heart rate monitoring policy is determined by pregnancy risk factors and admission cardiotocography.

Condition at birth of infants with previously absent or reverse umbilical artery end-diastolic flow velocities

In a case control study we assessed 47 fetuses with absent or reverse end-diastolic flow velocities (AREDFV) of the umbilical artery with respect to the mode of delivery, fetal acidosis, and abnormal neurological evaluations at the time of discharge from the department of pediatrics. We also studied a control group which was matched for gestational age and had normal umbilical artery flow velocity waveforms. Fetuses with AREDFV were delivered almost exclusively by cesarean section which was usually done for fetal distress. The number of fetuses with abnormal neurological signs was significantly increased compared to the control group. Fetuses with AREDFV showed an increased incidence of fetal acidosis. Forty per cent of these fetuses were delivered within one day of the first abnormal flow measurement; Sixty per cent were observed clinically for up to four weeks before delivery.

Comparison of dynamic image and pulsed Doppler ultrasonography for the diagnosis of the small-for-gestational-age fetus

OBJECTIVE

Because poor fetal growth is a significant cause of perinatal morbidity and mortality, a prospective study was undertaken to evaluate the ability of real-time ultrasonography and Doppler velocimetry to detect the small-for-gestational-age fetus.

STUDY DESIGN

A prospective study of 136 women at risk for fetal growth abnormalities was conducted. Patients were delivered within 3 weeks and had live-born, nonanomalous, singleton infants. The relative estimated fetal weight (estimated fetal weight divided by the median birth weight for gestational age) and the systolic/diastolic ratio were measured and compared with receiver-operator characteristic curves. In this method the area under the curve is the index of performance.

RESULTS

Forty-six infants were small for gestational age. Although both relative estimated fetal weight (area under the curve = 0.923) and systolic/diastolic ratio (area under the curve = 0.837) were significantly associated with the small for gestational age fetus, the former was more strongly correlated, p = 0.021.

CONCLUSION

Relative estimated weight is more sensitive and specific and should be the preferred parameter when gestational age is known.

The current status of maternal and fetal blood flow velocimetry

Significant progress has been achieved in regard to normative data for uteroplacental and fetal blood flow velocity and the factors which may affect these observations. Associations have been demonstrated between abnormal indices of maternal and fetal blood flow velocity and pregnancy-induced hypertension, fetal growth retardation, fetal blood gas measures, and intrapartum clinical fetal distress. However, in general, the predictive power is modest and no evidence has yet been provided to indicate that these measures can be used as a screening test in the general obstetric population. Continuing research is highly desirable. At the present time, the use of Doppler assessment of blood flow in pregnancy should be limited to the investigational setting.

Measurement of arterial blood flow by Doppler ultrasound

A review is given of quantitative techniques and clinical applications of arterial Doppler ultrasound. The currently available Doppler equipment of stand-alone continuous wave and pulsed wave units, duplex systems and colour flow systems is briefly described. Doppler ultrasound can be divided into procedures concerned with waveform analysis, volume flow measurement and more recently colour flow imaging. Arterial Doppler waveform analysis is considered for a number of areas including carotid, lower limb, renal and renal transplant, obstetrics, adult cerebral, neonatal cerebral, and tumour studies. Using a duplex scanner volume flow in arteries can be measured from estimates of vessel cross sectional area, mean Doppler frequency and beam-vessel angle. The errors associated with each of these measurements is discussed, and reports of experimentally determined in vivo accuracy of volume flow measurements made using this technique are considered. Other volume flow measurement techniques including the promising attenuation compensation method are also explored.

Quantitative techniques in arterial Doppler ultrasound

A brief review is given of quantitative Doppler ultrasound techniques applied to arteries. Doppler ultrasound procedures can be split into waveform analysis, volume flow measurement and, recently, colour flow imaging. The pulsatility of the Doppler waveform has been used to assess distal vascular resistance. In the obstetric field the increase in pulsatility seen in the umbilical artery waveform when there is placental disease is a good predictor of fetal compromise. Considerable effort has been undertaken over the past 20 years in the assessment of carotid artery stenosis using Doppler. Both the peak systolic velocity in the internal carotid and spectral broadening have been related to the degree of stenosis. More complex waveform analysis methods such as principal component analysis have been used, however these have not passed into clinical practice. Measurement of volume flow in arteries using a duplex system is attractive, but in practice there may be large errors and this technique is not routinely performed. Recently cardiac output has been measured by a Doppler device using the attenuation-compensation principle. This promising technique is currently under assessment. Colour flow Doppler raises new prospects for quantitation in Doppler. At present the colour flow Doppler image is assessed by eye. Quantitative techniques in colour flow are likely to be introduced as experience with these systems grows.